Skip to main content
Fig. 2 | BMC Pediatrics

Fig. 2

From: Serum neuron-specific enolase, magnetic resonance imaging, and electrophysiology for predicting neurodevelopmental outcomes of neonates with hypoxic-ischemic encephalopathy: a prospective study

Fig. 2

a Serum neuron-specific enolase 3-day NSE levels in relation to outcome (1: normal, 2: moderate delay, 3: severe delay). b Receiver operating characteristic (ROC) curves for 3-day NSE (cut-off point 27.3 μg/L) as a marker for distinguishing infants with developmental delay from infants with the normal outcome, ROC curves for 3-day NSE, Spearman correlation analysis, F = 59.349, P < 0.01

Back to article page